Market Cap 639.69M
Revenue (ttm) 7.87M
Net Income (ttm) -567.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,216.52%
Debt to Equity Ratio 0.01
Volume 6,719,800
Avg Vol 5,508,434
Day's Range N/A - N/A
Shares Out 340.26M
Stochastic %K 70%
Beta 1.37
Analysts Strong Sell
Price Target $7.17

Company Profile

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 332 208 6102
Address:
1500 Broadway, Suite 1401, New York, United States
Pastures
Pastures Jun. 27 at 12:38 PM
$NUVB What's your price target for NUVB? Thanks!
1 · Reply
Samalex
Samalex Jun. 27 at 7:29 AM
$NUVB Another Green Day might be on the agenda for us this morning. US-China trade talks are progressing well. The market condition looks conducive for Nuvation to move north of $2 handle. We’ll know in a few hours.
0 · Reply
Samalex
Samalex Jun. 27 at 5:51 AM
$NUVB Take the following with again of salt. I asked Grok regarding the 554.9K shares filled in the After-Hour session today at $1.97, a penny higher than the closing price of $1.96. Here’s a portion of Grok’s take: “… the 554.9K trade at $1.97 in after-hours is a mildly bullish sign due to its size, premium to the closing price, and the context of insider buying and high short interest. It could reflect institutional confidence or positioning for a catalyst like further pipeline progress or a short squeeze…” It’s reasonable to assume there must be a good reason for someone to shell out $1.08M to purchase 549.9K shares at $1.97, isn’t it? My guess is only an institution, a fund or an insider would have the deep pocket to shell out $1.08M in one purchase. Whats your take?
1 · Reply
Investandcashed
Investandcashed Jun. 27 at 4:42 AM
$NUVB https://youtu.be/1YTlLiR3xGM?si=U60BOmG8QNO755y6
0 · Reply
searchthealley
searchthealley Jun. 27 at 1:39 AM
$NUVB still here w the ones I came w
0 · Reply
GMEryder
GMEryder Jun. 26 at 11:56 PM
$NUVB $7 tomorrow 🤔
1 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 26 at 11:35 PM
$ALT if you have your health & youth & love in your life, @xXYoungGrasshopperXx , then you have more than most. And you should be damn proud of yourself for working 3 jobs - I’ve been there before brother. Work ethic is something that will always pay a dividend in life. This is a step back before two steps forward - the sell off was due to a handful of placebo patients that outperformed historically. I bet ALT will have more answers at the forthcoming MASH conference (the data is red hot still 🔥) I’m down on my $ALT investment and adding more. Same goes for $TNXP (fibromyalgia approval looming later this summer), $NUVB (also oddly oversold despite being approved with a likely best in class ROS1+ NSCLC therapy), and $KALV (oversold on their delayed PDUFA). Pemvi has BIC potential.
1 · Reply
Samalex
Samalex Jun. 26 at 11:27 PM
$NUVB Looked like a 554.9K buy order got filled either right at the close or during the After Hours session. Can anyone confirm? Thank you 🙏
1 · Reply
BioCapitalist99
BioCapitalist99 Jun. 26 at 9:15 PM
$NUVB Yo bro, friendly tip - tonight, hit the gym and go a few rounds with that..what’s-it-called..the punching bag? The hangy-hitty thing. You know, show it who’s boss. Your call. Maybe @ISEEITALLTHETIME can join you Very
2 · Reply
Randy_Lahey_Trevor_Corey
Randy_Lahey_Trevor_Corey Jun. 26 at 7:48 PM
$NUVB the “golden cross” what a crock of shit
1 · Reply
Latest News on NUVB
US FDA approves Nuvation Bio's lung cancer therapy

Jun 11, 2025, 1:45 PM EDT - 15 days ago

US FDA approves Nuvation Bio's lung cancer therapy


Nuvation Bio to Participate in Upcoming Investor Conferences

May 12, 2025, 4:05 PM EDT - 6 weeks ago

Nuvation Bio to Participate in Upcoming Investor Conferences


Nuvation Bio Inc. (NUVB) Q1 2025 Earnings Call Transcript

May 11, 2025, 10:05 PM EDT - 6 weeks ago

Nuvation Bio Inc. (NUVB) Q1 2025 Earnings Call Transcript


Top 4 Health Care Stocks That May Plunge This Quarter

Nov 11, 2024, 6:18 AM EST - 8 months ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS PODD QDEL


Nuvation Bio Completes Acquisition of AnHeart Therapeutics

Apr 10, 2024, 4:01 PM EDT - 1 year ago

Nuvation Bio Completes Acquisition of AnHeart Therapeutics


Pastures
Pastures Jun. 27 at 12:38 PM
$NUVB What's your price target for NUVB? Thanks!
1 · Reply
Samalex
Samalex Jun. 27 at 7:29 AM
$NUVB Another Green Day might be on the agenda for us this morning. US-China trade talks are progressing well. The market condition looks conducive for Nuvation to move north of $2 handle. We’ll know in a few hours.
0 · Reply
Samalex
Samalex Jun. 27 at 5:51 AM
$NUVB Take the following with again of salt. I asked Grok regarding the 554.9K shares filled in the After-Hour session today at $1.97, a penny higher than the closing price of $1.96. Here’s a portion of Grok’s take: “… the 554.9K trade at $1.97 in after-hours is a mildly bullish sign due to its size, premium to the closing price, and the context of insider buying and high short interest. It could reflect institutional confidence or positioning for a catalyst like further pipeline progress or a short squeeze…” It’s reasonable to assume there must be a good reason for someone to shell out $1.08M to purchase 549.9K shares at $1.97, isn’t it? My guess is only an institution, a fund or an insider would have the deep pocket to shell out $1.08M in one purchase. Whats your take?
1 · Reply
Investandcashed
Investandcashed Jun. 27 at 4:42 AM
$NUVB https://youtu.be/1YTlLiR3xGM?si=U60BOmG8QNO755y6
0 · Reply
searchthealley
searchthealley Jun. 27 at 1:39 AM
$NUVB still here w the ones I came w
0 · Reply
GMEryder
GMEryder Jun. 26 at 11:56 PM
$NUVB $7 tomorrow 🤔
1 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 26 at 11:35 PM
$ALT if you have your health & youth & love in your life, @xXYoungGrasshopperXx , then you have more than most. And you should be damn proud of yourself for working 3 jobs - I’ve been there before brother. Work ethic is something that will always pay a dividend in life. This is a step back before two steps forward - the sell off was due to a handful of placebo patients that outperformed historically. I bet ALT will have more answers at the forthcoming MASH conference (the data is red hot still 🔥) I’m down on my $ALT investment and adding more. Same goes for $TNXP (fibromyalgia approval looming later this summer), $NUVB (also oddly oversold despite being approved with a likely best in class ROS1+ NSCLC therapy), and $KALV (oversold on their delayed PDUFA). Pemvi has BIC potential.
1 · Reply
Samalex
Samalex Jun. 26 at 11:27 PM
$NUVB Looked like a 554.9K buy order got filled either right at the close or during the After Hours session. Can anyone confirm? Thank you 🙏
1 · Reply
BioCapitalist99
BioCapitalist99 Jun. 26 at 9:15 PM
$NUVB Yo bro, friendly tip - tonight, hit the gym and go a few rounds with that..what’s-it-called..the punching bag? The hangy-hitty thing. You know, show it who’s boss. Your call. Maybe @ISEEITALLTHETIME can join you Very
2 · Reply
Randy_Lahey_Trevor_Corey
Randy_Lahey_Trevor_Corey Jun. 26 at 7:48 PM
$NUVB the “golden cross” what a crock of shit
1 · Reply
Samalex
Samalex Jun. 26 at 7:36 PM
$NUVB July 18 $2.00 call options is on the verge of breaking the strike price. The July 18 $2.50 call options are the one that call options writers/sellers will try to protect. However, at the current share price, we still have 21% or about $0.50 cushion to move up without frustrating these call options sellers. Of course, we wish the best for investors who hold the July 18 $2.00 and $2.50. What good for these investors are good for all long investors.
1 · Reply
Doc_G
Doc_G Jun. 26 at 7:10 PM
$NUVB Update from ChatGPT **\$NUVB hourly golden cross just confirmed ⚡️📈** 50MA crossed above 200MA with volume surge — big green candle followed by healthy pause 🔥 MACD green, TTM squeeze still expanding 💚 Price holding above \$1.90 — eyeing \$2.03+ breakout next 🚀 Trend shift confirmed. #goldencross #squeezeplay #NUVB #biotech
0 · Reply
Jaxtyn1989
Jaxtyn1989 Jun. 26 at 7:06 PM
$NUVB added 3000 more shares at $1.85 today
1 · Reply
njbugatti
njbugatti Jun. 26 at 6:59 PM
$NUVB Announcement incoming......we've completed our first sale and just received the $150,000,000 deposit from Sagard!!
2 · Reply
BioCapitalist99
BioCapitalist99 Jun. 26 at 6:59 PM
$NUVB strong rebound incoming
0 · Reply
blueskymor
blueskymor Jun. 26 at 6:45 PM
$NUVB go $7!!!!!
0 · Reply
searchthealley
searchthealley Jun. 26 at 6:44 PM
$NUVB 🌟 do a spin
0 · Reply
Patje80
Patje80 Jun. 26 at 6:44 PM
$NUVB come on
0 · Reply
Kingtan
Kingtan Jun. 26 at 6:42 PM
$NUVB lets go baby 😘
0 · Reply
Samalex
Samalex Jun. 26 at 6:30 PM
0 · Reply
Samalex
Samalex Jun. 26 at 6:14 PM
$NUVB is a sweet short squeeze coming soon? Share distribution: Institutions: 224,681,423 66.23% Insiders: 114,961,840 33.89% Short interest: 56,084,212 24.49% Total shares accounted for (sum of the above): 395,727,075 Total Outstanding shares: 339,262,976 Share Borrowed 56,464,019
2 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 26 at 5:53 PM
$ALT $NKTR $KALV $NUVB all oversold. Buying opportunities 👍 ☘️ 🐂
2 · Reply